Ownership history in Eversept Partners, LP · 17 quarters on record
This page tracks every 13F SEC filing in which Eversept Partners, LP reported a position in GOSSAMER BIO INC (GOSS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 925,233 | -770,529 | -45.4% | 0.17% | $2.4M | $2.63 |
| 2025 Q2 | REDUCED | 1,695,762 | -2,201,079 | -56.5% | 0.19% | $2.1M | $1.23 |
| 2025 Q1 | REDUCED | 3,896,841 | -1,081,617 | -21.7% | 0.44% | $4.3M | $1.10 |
| 2024 Q4 | UNCHANGED | 4,978,458 | — | 0% | 0.40% | $4.5M | $0.90 |
| 2024 Q3 | REDUCED | 4,978,458 | -505,690 | -9.2% | 0.34% | $4.9M | $0.99 |
| 2024 Q2 | REDUCED | 5,484,148 | -510,324 | -8.5% | 0.34% | $4.9M | $0.90 |
| 2024 Q1 | REDUCED | 5,994,472 | -438,243 | -6.8% | 0.47% | $7.1M | $1.18 |
| 2023 Q4 | ADDED | 6,432,715 | +2,004,858 | +45.3% | 0.52% | $5.9M | $0.91 |
| 2023 Q3 | ADDED | 4,427,857 | +3,678,160 | +490.6% | 0.31% | $3.7M | $0.83 |
| 2023 Q2 | REDUCED | 749,697 | -602,368 | -44.6% | 0.09% | $900K | $1.20 |
As of 2025 Q4 — sorted by position size